Lv1
40 积分 2025-12-06 加入
Pharmacokinetics and Safety Profile of Bleselumab (ASKP1240) in Patients With Moderate-To-Severe Plaque Psoriasis: Results from a Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Sequential, Multiple-Dose Escalation Study
22天前
已完结
AB0803 EFFICACY OF TILDRAKIZUMAB IN PsA: DAS28-CRP SCORES THROUGH WEEK 52
22天前
已关闭
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial
23天前
已完结
Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis
1个月前
已完结
Prevalence and incidence of psoriasis and psoriatic arthritis
2个月前
已完结
[Can TDABC (Time-Driven Activity-Based Costing) help the NOVO hospital's medical biology laboratory to value the appropriate prescription? - Role of the biologist in reducing healthcare costs]
3个月前
已完结
Time-driven Activity-based Costing Analysis of Fluorescein Angiography
6个月前
已关闭
A time-driven activity-based costing model to improve health-care resource use in Mirebalais, Haiti
7个月前
已完结
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
8个月前
已关闭
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib
9个月前
已关闭